在T2DM-MAFLD患者中治疗塞马格卢提德的肝脏结果的多omics分析:一个单中心,纵向,数据驱动的研究
Shu Niu1, Shuchun Chen2, Di Wu3
1Department of Endocrine, Shijiazhuang People's Hospital, Shijiazhuang, Hebei, China.
Frontiers in endocrinology
|October 17, 2025
概括
在患有2型糖尿病和脂肪肝疾病的患者中,塞马格卢提德治疗改善了代谢和肝脏健康. 这项研究揭示了塞马格卢提德如何增强脂肪酸代谢并减少炎症.
科学领域:
- 代谢学和蛋白质学
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
背景情况:
- 代谢相关的脂肪肝疾病 (MAFLD) 是一种普遍存在的肝脏疾病,通常与2型糖尿病 (T2DM) 一起发生.
- MAFLD的发病包括代谢失调,包括脂肪酸氧化和炎症受损.
- 类似葡萄糖-1受体激动剂 (GLP-1RA) 显示了代谢益处,但它们对MAFLD的直接影响需要阐明.
研究的目的:
- 在T2DM患有MAFLD的患者中研究赛马格卢提德对肝脏的益处的分子机制.
- 为了分析血清蛋白质和代谢学变化诱导的塞马格卢提德治疗.
- 了解塞马格卢提德如何影响与MAFLD相关的代谢途径.
主要方法:
- 一项为期12周的长期研究,对75名2型糖尿病患者进行了MAFLD治疗,这些患者接受了semaglutide治疗.
- 在基线和治疗后使用4D-DIA蛋白质组学和LC-MS分析的血清样本.
- 整合蛋白质组,代谢组和临床数据,用于生物标志物发现和途径分析.
主要成果:
- 塞马格卢提德显著改善了血糖控制 (HbA1c),BMI,胰岛素抵抗 (HOMA-IR),肝功能和肝硬度.
- 确定了203种不同的代谢物和61种蛋白质,显示脂肪酸和炎症媒介减少,肉酸衍生物增加.
- 途径分析表明脂肪酸代谢,PPAR信号传递和NAFLD相关途径的调节.
结论:
- 在T2DM-MAFLD患者中,塞马格卢提德治疗会改变血清蛋白质组和代谢组概况.
- 潜在的机制包括增强的线粒体脂肪酸氧化,降低脂毒性和抑制炎症.
- 这些发现支持塞马格卢提德作为MAFLD的治疗选择,并进一步了解GLP-1 RA多器官效应.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Bioavailability Study Design: Single Versus Multiple Dose Studies
205
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
205
Chronic Pancreatitis II: Collaborative Care
311
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
311
